Aaj TV English News - Health https://english.aaj.tv/ Aaj TV English en-Us Copyright 2026 Mon, 06 Apr 2026 14:01:08 +0500 Mon, 06 Apr 2026 14:01:08 +0500 60 Novo Nordisk’s obesity drug falls short against Eli Lilly’s in trial https://english.aaj.tv/news/330452959/novo-nordisks-obesity-drug-falls-short-against-eli-lillys-in-trial <p><strong>Novo Nordisk said on Monday its experimental obesity drug CagriSema did not meet the primary endpoint in a trial designed to show it was non-inferior to competitor Eli Lilly’s tirzepatide in reducing body weight.</strong></p> <p>Novo Nordisk’s share price fell 8%.</p> <p>Novo Nordisk said CagriSema achieved a 23% reduction in body weight over 84 weeks, compared to 25.5% for Eli Lilly’s tirzepatide in the trial.</p> Novo Nordisk said on Monday its experimental obesity drug CagriSema did not meet the primary endpoint in a trial designed to show it was non-inferior to competitor Eli Lilly’s tirzepatide in reducing body weight.

Novo Nordisk’s share price fell 8%.

Novo Nordisk said CagriSema achieved a 23% reduction in body weight over 84 weeks, compared to 25.5% for Eli Lilly’s tirzepatide in the trial.

]]> Health https://english.aaj.tv/news/330452959 Mon, 23 Feb 2026 14:55:48 +0500 none@none.com (Reuters) The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark. – Reuters